Oral versus intravenous high-dose methylprednisolone for treatment of relapses in patients with multiple sclerosis (COPOUSEP)
暂无分享,去创建一个
G. Edan | D. Laplaud | D. Veillard | V. Deburghgraeve | S. Wiertlewski | M. Coustans | C. Lebrun | F. Zagnoli | S. Hamonic | E. L. Page | R. Wardi | MD a Emmanuelle Le Page | MD b David Veillard | Prof David A Laplaud | Stéphanie Hamonic MD c | MD d Rasha Wardi | MD e Christine Lebrun | Fabien Zagnoli MD f | MD g Sandrine Wiertlewski | MD a Véronique Deburghgraeve | Marc Coustans MD h | Prof Gilles Edan